# Skye Bioscience, Inc. (SKYE) — delisting/forced [announced]
Source: sec.gov · situation sit_0799b25c7527e788e47a · public 2228037358746980865 · retrieved 2026-08-20T12:56:50.707Z

## Overview
Skye Bioscience, Inc. is a pharmaceutical company that develops cannabis-derived therapeutics and operates in the pharmaceutical preparations industry.

On August 18, 2026, Skye Bioscience, Inc. received a written notice from Nasdaq's Listing Qualifications Department indicating the company failed to comply with Nasdaq Capital Market Listing Rule 5550(b)(1) due to negative stockholders' equity of ($497,307) as of June 30, 2026, versus the required $2,500,000 minimum. The company has 45 calendar days, until October 2, 2026, to submit a plan to regain compliance. If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from the notice date (until February 14, 2027) to evidence compliance. The common stock will continue trading under the symbol "SKYE" on Nasdaq Capital Market during this period.

## Terms
- Counterparty: The Nasdaq Stock Market LLC · Deal value: $2.5M

## Key dates
- Announced 2026-08-18 · Expected close 2026-10-02

## Timeline
- 2026-08-18 · 8-K (0001628280-26-057804): 8-K - Skye Bioscience, Inc. — *Skye Bioscience, Inc. is a pharmaceutical company that develops cannabis-derived therapeutics and operates in the pharmaceutical preparations industry.* On August 18, 2026, Skye Bioscience, Inc. received a written notice from Nasdaq's Listing Qualifications Department indicating the company failed to comply with Nasdaq Capital Market Listing Rule 5550(b)(1) due to negative stockholders' equity of ($497,307) as of June 30, 2026, versus the required $2,500,000 minimum. The company has 45 calendar days, until October 2, 2026, to submit a plan to regain compliance. If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from the notice date (until February 14, 2027) to evidence compliance. The common stock will continue trading under the symbol "SKYE" on Nasdaq Capital Market during this period.
  https://www.sec.gov/Archives/edgar/data/1516551/0001628280-26-057804.txt

## Citations
- 0001628280-26-057804 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000162828026057804